These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6303783)

  • 1. Translational barrier in central region of encephalomyocarditis virus genome. Modulation by elongation factor 2 (eEF-2).
    Svitkin YV; Agol VI
    Eur J Biochem; 1983 Jun; 133(1):145-54. PubMed ID: 6303783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rate of polypeptide chain elongation in a cell-free system from Krebs II ascites cells.
    Mathews MB; Osborn M
    Biochim Biophys Acta; 1974 Mar; 340(2):147-52. PubMed ID: 4364993
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro translation of encephalomyocarditis viral RNA: synthesis of capsid precursor-like polypeptides.
    Hunt LA
    Virology; 1976 Apr; 70(2):484-92. PubMed ID: 178097
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell-free synthesis of encephalomyocarditis virus.
    Svitkin YV; Sonenberg N
    J Virol; 2003 Jun; 77(11):6551-5. PubMed ID: 12743313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of capsid and noncapsid viral proteins in response to encephalomyocarditis virus ribonucleic acid in animal cell-free systems.
    Dobos P; Kerr IM; Martin EM
    J Virol; 1971 Oct; 8(4):491-9. PubMed ID: 4331652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribosomes terminated in vitro are in a tight association with non-phosphorylated elongation factor 2 (eEF-2) and GDP.
    Davydova EK; Malinin NL; Ovchinnikov LP
    Eur J Biochem; 1993 Jul; 215(2):291-6. PubMed ID: 8344297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Factor facilitating complete translation of the encephalomyocarditis virus genome].
    Svitkin IuV; Agol VI
    Dokl Akad Nauk SSSR; 1981; 258(4):1013-5. PubMed ID: 6265184
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanism of premature polypetide termination in a mouse ascites cell-free system programmed by encephalomyocarditis viral RNA.
    Hunt LA
    J Virol; 1976 May; 18(2):788-92. PubMed ID: 178909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of encephalomyocarditis virus RNA translation in wheat embryo extracts by rabbit reticulocyte ribosomal wash.
    Shih DS; Shih CY; Kaesberg P
    J Virol; 1980 Aug; 35(2):566-71. PubMed ID: 6255195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete translation of encephalomyocarditis virus RNA and faithful cleavage of virus-specific proteins in a cell-free system from Krebs-2 cells.
    Svitkin YV; Agol VI
    FEBS Lett; 1978 Mar; 87(1):7-11. PubMed ID: 204520
    [No Abstract]   [Full Text] [Related]  

  • 11. Possibility of the transformation of eEF-2 (100 kDa) to eEF-2 (65 kDa) in the peptide elongation process in vitro.
    Gajko A; Sredzińska K; Galasiński W; Gindzieński A
    Biochem Biophys Res Commun; 1999 Feb; 255(2):535-8. PubMed ID: 10049743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein synthesis directed by encephalomyocarditis virus RNA. II. The in vitro synthesis of high molecular weight proteins and elements of the viral capsid.
    Boime I; Aviv H; Leder P
    Biochem Biophys Res Commun; 1971 Nov; 45(3):788-95. PubMed ID: 4331472
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of a viral protein involved in post-translational maturation of the encephalomyocarditis virus capsid precursor.
    Lawrence C; Thach RE
    J Virol; 1975 Apr; 15(4):918-28. PubMed ID: 163926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translational elongation rate changes in encephalomyocarditis virus-infected and interferon-treated cells.
    Ramabhadran TV; Thach RE
    J Virol; 1981 Aug; 39(2):573-83. PubMed ID: 6168777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leader polypeptides encoded in the 5'-region of the encephalomyocarditis virus genome.
    Kazachkov YuA ; Chernovskaya TV; Siyanova EYu ; Svitkin YuV ; Ugarova TYu ; Agol VI
    FEBS Lett; 1982 May; 141(2):153-6. PubMed ID: 6284551
    [No Abstract]   [Full Text] [Related]  

  • 16. [Virus-specific proteins associated with components of protein-synthesizing systems in Krebs II ascites carcinoma cells infected with encephalomyocarditis virus].
    Skarlat IV; Kalinina NO; Medvedkina OA; Iatsyna AA
    Mol Biol (Mosk); 1976; 10(5):1142-52. PubMed ID: 223028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A detailed kinetic analysis of the in vitro synthesis and processing of encephalomyocarditis virus products.
    Jackson RJ
    Virology; 1986 Feb; 149(1):114-27. PubMed ID: 3004023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effective cell-free system for translation of encephalomyocarditis virus RNA].
    Svitkin IuV; Agol VI
    Dokl Akad Nauk SSSR; 1978; 238(3):744-7. PubMed ID: 203436
    [No Abstract]   [Full Text] [Related]  

  • 19. The synthesis of encephalomyocarditis virus polypeptides in infected L-cells and cell-free systems.
    Esteban M; Kerr IM
    Eur J Biochem; 1974 Jun; 45(2):567-76. PubMed ID: 4369366
    [No Abstract]   [Full Text] [Related]  

  • 20. A translation system reconstituted with human factors proves that processing of encephalomyocarditis virus proteins 2A and 2B occurs in the elongation phase of translation without eukaryotic release factors.
    Machida K; Mikami S; Masutani M; Mishima K; Kobayashi T; Imataka H
    J Biol Chem; 2014 Nov; 289(46):31960-31971. PubMed ID: 25258322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.